Glipizide and Metformin Hydrochloride (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Glipizide and Metformin Hydrochloride drug offered from KAISER FOUNDATION HOSPITALS. This Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
NON-PROPRIETARY NAME: | Glipizide and Metformin Hydrochloride |
SUBSTANCE NAME: | GLIPIZIDE; METFORMIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-04-22 |
END MARKETING DATE: | 0000-00-00 |
Glipizide and Metformin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Glipizide and Metformin Hydrochloride from KAISER FOUNDATION HOSPITALS |
LABELER NAME: | KAISER FOUNDATION HOSPITALS |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; 500(mg/1; mg/1) |
START MARKETING DATE: | 2016-04-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0179-0205_dbcbe96b-0dff-406a-b655-83578a688f72 |
PRODUCT NDC: | 0179-0205 |
APPLICATION NUMBER: | ANDA077270 |
Other GLIPIZIDE; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: